S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.16%) $0.928
USD/NOK
(0.30%) $10.87
USD/GBP
(0.03%) $0.792
USD/RUB
(0.02%) $92.60

Realtime updates for OPKO Health Inc [OPK]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research
BUY
66.67%
return 1.85%
SELL
0.00%
return 3.69%
Last Updated28 Mar 2024 @ 16:00

12.15% $ 1.200

BUY 72586 min ago

@ $0.976

Issued: 7 Feb 2024 @ 15:19


Return: 22.98%


Previous signal: Feb 7 - 13:02


Previous signal: Sell


Return: -0.80 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally...

Stats
Today's Volume 28.87M
Average Volume 14.85M
Market Cap 836.39M
EPS $0 ( 2024-02-27 )
Next earnings date ( $-0.0900 ) 2024-05-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.80
ATR14 $0.0100 (0.83%)
Insider Trading
Date Person Action Amount type
2024-03-18 Frost Phillip Md Et Al Buy 500 000 Common Stock
2024-03-14 Frost Phillip Md Et Al Buy 500 000 Common Stock
2024-03-13 Frost Phillip Md Et Al Buy 500 000 Common Stock
2024-03-12 Frost Phillip Md Et Al Buy 600 000 Common Stock
2024-02-28 Frost Phillip Md Et Al Buy 500 000 Common Stock
INSIDER POWER
100.00
Last 100 transactions
Buy: 13 268 025 | Sell: 0

Volume Correlation

Long: 0.02 (neutral)
Short: 0.97 (very strong)
Signal:(54.231) Expect same movement, but be aware

OPKO Health Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

OPKO Health Inc Correlation - Currency/Commodity

The country flag 0.00
( neutral )
The country flag -0.16
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.22
( neutral )

OPKO Health Inc Financials

Annual 2023
Revenue: $863.50M
Gross Profit: $232.10M (26.88 %)
EPS: $-0.250
Q4 2023
Revenue: $181.90M
Gross Profit: $23.20M (12.75 %)
EPS: $-0.0885
Q3 2023
Revenue: $178.60M
Gross Profit: $47.70M (26.71 %)
EPS: $-0.110
Q2 2023
Revenue: $265.42M
Gross Profit: $126.48M (47.65 %)
EPS: $-0.0261

Financial Reports:

No articles found.

OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators